Original research
by
Hoffman, Kim A. et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
We assessed the effects of COVID-19-related changes on take-home methadone dosing in two opioid treatment programs serving five rural Oregon counties.
Findings/Key points
Take-home methadone dose relaxations were associated with increased methadone take-home doses, improved retention, and decreased UDT opioid positive results among clinically stable patients. Qualitative findings suggest that fewer take-home restrictions are feasible and desirable and do not pose safety or public health harms.
Design/methods
Mixed methods
Keywords
Policy/Regulatory
About PWUD
Outcomes
Illegal drugs
Substitution/OAT
Carries/take-home doses